Invention Grant
US08828936B2 Therapeutic use of SCGB3A2 有权
治疗使用SCGB3A2

Therapeutic use of SCGB3A2
Abstract:
The present disclosure is generally related to methods of using the secretory protein SCGB3A2 for promoting lung development and treating lung disease. Some embodiments are, for example, methods for treating and inhibiting the development of neonatal respiratory distress. Other embodiments are methods of promoting lung development in damaged or diseased lungs. Also disclosed are methods for inhibiting lung damage due to anti-cancer agents.
Public/Granted literature
Information query
Patent Agency Ranking
0/0